English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Open

In 2015, there were 47 million people with dementia worldwide. The overall number of people with dementia is projected to reach 132 million in 2050, 51% of whom will be from Asian countries. Japan has the highest prevalence of dementia among the OECD countries, where 2% of inhabitants (5 million) are living with dementia. There are significant unmet needs regarding the effectiveness of antidementia drug use in real‐world settings. Populations in settings of clinical trials on antidementia drugs generally deviate from those in clinical practice settings (eg, exclusion of people aged ≥85 years).

Antidementia drug use in Japan: Bridging the research‐to‐practice gap